AF Global Limited (SGX:L38)

Ligand Pharmaceuticals Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.95	19.22	14.62	7.33	5.39	8.56
Short-Term Investments	18.72	22	21.98	21.16	22.06	22.09
Cash & Short-Term Investments	37.67	41.22	36.6	28.49	27.45	30.65
Cash Growth	6.15%	12.64%	28.46%	3.79%	-10.44%	-1.87%
Accounts Receivable	0.3	0.94	1.19	1.3	0.14	0.03
Other Receivables	0.43	0.2	0.2	0.16	0.67	0.75
Receivables	0.73	1.13	1.39	1.46	0.8	0.78
Inventory	0.12	0.2	0.13	0.22	0.12	0.15
Prepaid Expenses	0.28	0.27	0.2	0.15	0.18	0.21
Other Current Assets	-	0.11	0.05	0.08	0.07	53.13
Total Current Assets	38.8	42.93	38.37	30.39	28.63	84.93
Property, Plant & Equipment	143.53	146.52	191.48	197.34	208.19	231
Long-Term Investments	71.92	72.63	85.47	90.29	94.24	36.4
Other Intangible Assets	0.02	0.03	0.03	0.03	0.04	0.04
Long-Term Deferred Tax Assets	0.24	0.55	2.08	0.25	0.25	0.36
Total Assets	254.51	262.66	317.42	318.3	331.34	352.72
Accounts Payable	1.77	3.23	1.81	1.73	0.98	0.72
Accrued Expenses	-	6.14	4.73	4.57	4.02	4.6
Current Portion of Long-Term Debt	3.97	5.39	13.62	20.01	12.09	11.63
Current Portion of Leases	0.05	0.05	0.04	0.03	0.03	0.08
Current Income Taxes Payable	0.87	0.33	0.3	0.08	0.08	0.25
Other Current Liabilities	5.36	0.48	1.01	0.82	0.82	1.09
Total Current Liabilities	12	15.61	21.5	27.24	18.03	18.37
Long-Term Debt	8.96	8.22	9.32	3.43	13.19	12.92
Long-Term Leases	0.68	0.75	0.77	0.83	0.86	0.88
Long-Term Deferred Tax Liabilities	24.75	25.18	24.36	24.45	25.2	26.82
Total Liabilities	46.39	49.76	55.95	55.95	57.29	58.98
Common Stock	172.57	172.57	209.52	209.52	209.52	209.52
Retained Earnings	-35.62	-37.05	-31.15	-38.07	-33.82	-28.12
Comprehensive Income & Other	13.6	16.79	30.5	40.09	46.27	52.76
Total Common Equity	150.55	152.31	208.87	211.54	221.97	234.16
Minority Interest	57.57	60.6	52.6	50.81	52.09	59.59
Shareholders' Equity	208.12	212.91	261.47	262.35	274.05	293.74
Total Liabilities & Equity	254.51	262.66	317.42	318.3	331.34	352.72
Total Debt	13.65	14.4	23.75	24.3	26.18	25.51
Net Cash (Debt)	24.02	26.82	12.85	4.19	1.27	5.14
Net Cash Growth	85.41%	108.77%	206.59%	229.66%	-75.28%	-76.71%
Net Cash Per Share	0.02	0.03	0.01	0.00	0.00	0.00
Filing Date Shares Outstanding	1,056	1,056	1,056	1,056	1,056	1,056
Total Common Shares Outstanding	1,056	1,056	1,056	1,056	1,056	1,056
Working Capital	26.8	27.33	16.87	3.16	10.6	66.56
Book Value Per Share	0.14	0.14	0.20	0.20	0.21	0.22
Tangible Book Value	150.53	152.28	208.85	211.51	221.93	234.12
Tangible Book Value Per Share	0.14	0.14	0.20	0.20	0.21	0.22
Land	-	178.33	216.8	220.1	228.39	248.28
Machinery	-	29.28	28.87	29.88	33.06	35.7
Construction In Progress	-	0.05	3.96	4	4.18	4.54

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.